(Q45154328)

10 December 2017

title

Depressive classification and prediction of response to phenelzine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476367

5 July 2022

Depressive Classification and Prediction of Response to Phenelzine (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

1 June 2023

author name string

E. S. Paykel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476367

5 July 2022

R. R. Parker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476367

5 July 2022

R. J. Penrose

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476367

5 July 2022

E. R. Rassaby

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476367

5 July 2022

language of work or name

English

0 references

publication date

1 June 1979

1 reference

full work available at URL

10 December 2017

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000059286

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

British Journal of Psychiatry

1 June 2023

published in

1 reference

10 December 2017

volume

134

1 reference

10 December 2017

page(s)

572-581

1 reference

THE INFLUENCE OF MEDICATION (IMIPRAMINE) AND DOCTOR IN RELIEVING DEPRESSED PSYCHONEUROTIC OUTPATIENTS.

10 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

A Statistical Review of Controlled Trials of Imipramine and Placebo in the Treatment of Depressive Illnesses

1 June 2023

3

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Behaviour Therapy versus Drug Therapy in the Treatment of Phobic Neurosis

1 June 2023

4

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Typological Prediction of Response to Amitriptyline: a Replication Study

1 June 2023

6

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Clinical response to amitriptyline among depressed women.

1 June 2023

7

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

The endogenous-neurotic continuum in depression: Rater independence and factor distributions

1 June 2023

8

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Factor patterns in depression. A replication study

1 June 2023

9

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

A clinical and biochemical study of a trial of iproniazid in the treatment of depression

1 June 2023

10

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Nosology of depression and differential response to drugs

1 June 2023

11

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

The classification of depressions: a review of contemporary confusion

1 June 2023

12

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

A Double-Blind Trial of Phenelzine and Amitriptyline in Depressed Out-Patients. a Possible Differential Effect of the Drugs on Symptoms

1 June 2023

13

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Interaction of Drug Therapy With Marital Therapy in Depressive Patients

1 June 2023

15

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Depressive Typologies and Response to Amitriptyline

1 June 2023

16

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients.

1 June 2023

17

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Towards Rational Therapy with Monoamine Oxidase Inhibitors

1 June 2023

18

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Treatment of phobic states with antidepressants. A retrospective study of 246 patients

1 June 2023

19

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Drugs and Group Psychotherapy in Neurotic Depression

1 June 2023

21

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Comparison of antidepressant drugs in depressive illnesses

1 June 2023

22

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Treatment setting and clinical depression

1 June 2023

23

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Classification of Depressed Patients: A Cluster Analysis Derived Grouping

1 June 2023

24

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

DIFFERENTIAL RESPONSE OF HOSPITALIZED DEPRESSED PATIENTS TO SOMATIC THERAPY

1 June 2023

25

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

A report on the effects of phenelzine (nardil), a monoamine oxidase inhibitor, in depressed patients

1 June 2023

27

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study.

1 June 2023

28

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

The managment of severe agoraphobia: a comparison of iproniazid and systematic desensitization

1 June 2023

30

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

A comparison of imipramine, electroconvulsive therapy and placebo in the treatment of depressions

1 June 2023

34

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Drug therapy of depression. Amitriptyline, perphenazine, and their combination in different syndromes

1 June 2023

38

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Phenelzine in phobic anxiety: a controlled trial

1 June 2023

40

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Prediction of tricyclic antidepressant response: a critical review

1 June 2023

41

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

Drug therapy in depressions. Controlled evaluation of imipramine, isocarboxazide, dextroamphetamineamobarbital, and placebo

1 June 2023

42

1 reference

https://api.crossref.org/works/10.1192/BJP.134.6.572

1 June 2023

Identifiers

1 reference

10 December 2017

1 reference